Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01652378 · ClinicalTrials.gov registry record
Pharmacologic MRI in Cocaine Addiction
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 12
- Enrollment target
NCT01652378: Completed study, sponsored by University of Texas Southwestern Medical Center.
NCT01652378 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01652378 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
In the proposed study, the investigators will assess the brain response to medication probes the investigators have previously studied with SPECT. The brain response to ondansetron and lidocaine infusions will be measured Arterial Spin Labeling and functional connectivity MRI (fcMRI).
Primary Outcome
change in BOLD response to drug infusion (ondansetron, lidocaine).
Interventions
- DRUG ondansetron, lidocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2012-08 |
| Est. Completion | 2016-08 |
What the finished NCT01652378 record still lists
NCT01652378 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which ondansetron, lidocaine is the first listed.
NCT01652378 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01652378 about?
NCT01652378 is a clinical study titled "Pharmacologic MRI in Cocaine Addiction". In the proposed study, the investigators will assess the brain response to medication probes the investigators have previously studied with SPECT. The brain response to ondansetron and lidocaine infusions will be measured Arterial Spin Labeling and functional connectivity MRI (fcMRI).
What is the current status of trial NCT01652378?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2012-08. Estimated completion is 2016-08.
What interventions are being tested in trial NCT01652378?
The interventions under investigation include: ondansetron, lidocaine (DRUG).
Who is sponsoring clinical trial NCT01652378?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia